What is double sequential defibrillator
Reading File
Searching PubMed
double sequential defibrillation refractory ventricular fibrillation
Finding Sources
Reading Article
Reading File
Reading File
I now have all the information needed for a thorough answer.
Double Sequential Defibrillation (DSD)
Definition
Double sequential defibrillation (also called dual sequential defibrillation or double sequential external defibrillation, DSED) is a technique using two separate defibrillators to deliver near-simultaneous shocks to a patient in refractory ventricular fibrillation (VF) - VF that persists despite multiple standard shocks and antiarrhythmic drugs.
- Tintinalli's Emergency Medicine, p. 201: "a recent practice employing the use of two sets of manual defibrillators simultaneously to attempt to double the defibrillation energy in refractory ventricular fibrillation patients who do not respond to multiple shocks and antiarrhythmic drugs."
When Is It Used?
It is considered for patients with shock-refractory VF, typically defined as:
- 3 or more sustained episodes of VT/VF, or
- 3 or more ICD (implantable cardioverter-defibrillator) shocks within 24 hours,
- Failing to respond to quality CPR, multiple standard shocks, and drugs (epinephrine, amiodarone/lidocaine).
How It Is Performed
- A first set of pads is placed in the standard apex-sternum (anterior-lateral) position.
- A second set of pads is placed in the anterior-posterior position - a different vector.
- Both defibrillators are charged to maximal output.
- Shocks are delivered simultaneously or in very rapid succession, requiring team coordination.
The total of four pads creates two different current vectors through the myocardium.
Proposed Mechanism
The exact mechanism is not fully understood, but the leading theories are:
- Lower defibrillation threshold - the combined energy from two vectors may depolarize myocardial cells that a single shock failed to reach.
- Override of the relative refractory period - shocking from a different vector may capture cells that are in a different phase of their action potential.
- Greater myocardial mass depolarized - two vectors together cover more cardiac tissue, reducing the critical mass of fibrillating cells needed to sustain VF.
Key Evidence - DOSE VF Trial (NEJM, 2022)
The landmark DOSE VF RCT (Cheskes et al., PMID: 36342151) was a cluster-randomized trial in 6 Canadian paramedic services involving 405 patients with refractory out-of-hospital cardiac arrest. It compared three strategies:
| Strategy | Survival to Discharge | Good Neurologic Outcome |
|---|---|---|
| Standard defibrillation | 13.3% | ~13% |
| Vector-change (VC) defibrillation | 21.7% (RR 1.71) | Not significantly better |
| DSED | 30.4% (RR 2.21) | Significantly better (RR 2.21) |
Key findings:
- DSED roughly doubled survival compared to standard defibrillation.
- DSED was also associated with significantly better neurologic outcomes.
- Vector-change alone (just switching to anterior-posterior pads without a second defibrillator) also improved survival, suggesting pad position matters independently.
The trial was stopped early due to the COVID-19 pandemic, so it was underpowered, but results were striking.
Vector-Change Defibrillation (a related technique)
The DOSE VF trial also evaluated vector-change (VC) defibrillation - simply switching the existing pads from anterior-lateral to anterior-posterior position before the next shock (no second defibrillator needed). This simpler maneuver also improved survival (RR 1.71), making it a practical alternative when a second defibrillator is unavailable.
Concerns and Limitations
- Equipment damage: Manufacturers have raised concerns that two defibrillators firing simultaneously could cause electrical damage to the devices.
- Rescuer safety: There is a theoretical risk of inadvertent shock to team members; double gloves or electrically safe gloves are recommended. No deaths from rescuer electrocution have been reported in the literature.
- Evidence base: Most earlier evidence was anecdotal. The DOSE VF trial provided the first rigorous RCT data, though it was underpowered due to early stopping.
- Guideline status: As of the most recent major guidelines, DSED is considered a reasonable option for refractory VF, but it is not yet a Class I recommendation in all guidelines.
Recent Systematic Review Update (2024)
A 2024 meta-analysis (Yu et al., PMID: 39127020, Am J Emerg Med) of defibrillation strategies for refractory VF confirmed DSED as the most effective among alternate strategies, consistent with DOSE VF findings.
Summary: Double sequential defibrillation is a rescue technique for refractory VF where two defibrillators are used with pads in two different orientations to deliver near-simultaneous high-energy shocks. The DOSE VF trial showed it roughly doubles survival compared to standard defibrillation, making it one of the most impactful resuscitation advances of the last decade.
This is a shared conversation. Sign in to Orris to start your own chat.